Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Relapse”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Large-scale testing (Phase 3)Ended earlyNCT03593213
What this trial is testing

Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia

Who this might be right for
Schizophrenia
AbbVie 587
Not applicableUnknownNCT00192582
What this trial is testing

AIMHI NT Relapse Prevention Trial

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychoses, Substance Induced+2 more
Menzies School of Health Research 90
Post-approval studies (Phase 4)Ended earlyNCT00946985
What this trial is testing

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Who this might be right for
Schizophrenia
Ortho-McNeil Janssen Scientific Affairs, LLC 163
Not applicableUnknownNCT04230590
What this trial is testing

Health Outcomes Via Positive Engagement in Schizophrenia

Who this might be right for
Schizophrenia Spectrum Disorders
Institute of Mental Health, Singapore 100
Post-approval studies (Phase 4)Ended earlyNCT01576640
What this trial is testing

Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia

Who this might be right for
Nicotine DependenceSchizophrenia
Massachusetts General Hospital 17
Not applicableStudy completedNCT02220504
What this trial is testing

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

Who this might be right for
SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
Fundación Marques de Valdecilla 68
Not applicableStudy completedNCT01731171
What this trial is testing

Probiotics to Prevent Relapse After Hospitalization for Mania

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Sheppard Pratt Health System 66
Not applicableStudy completedNCT00399334
What this trial is testing

PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Janssen-Cilag, S.A. 1,607
Not applicableLooking for participantsNCT06613334
What this trial is testing

Voice-Based Biomarkers: A Novel Approach to Monitoring and Predicting Schizophrenia Relapses

Who this might be right for
Schizophrenia
Centre Hospitalier St Anne 200
Post-approval studies (Phase 4)UnknownNCT02210962
What this trial is testing

Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia

Who this might be right for
Schizophrenia
Medical University of Lodz 80
Large-scale testing (Phase 3)Study completedNCT00143351
What this trial is testing

Mozart Relapse Study

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 75
Post-approval studies (Phase 4)Study completedNCT00299702
What this trial is testing

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 355
Not applicableStudy completedNCT03019887
What this trial is testing

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

Who this might be right for
Schizophrenia Relapse
Juntendo University 139
Not applicableStudy completedNCT02819349
What this trial is testing

Texting for Relapse Prevention

Who this might be right for
SchizophreniaSchizoaffective Disorder
Center for Innovative Public Health Research 40
Not applicableStudy completedNCT02224430
What this trial is testing

Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body Sensors

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Alabama at Birmingham 40
Large-scale testing (Phase 3)Study completedNCT00228462
What this trial is testing

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Who this might be right for
Schizophrenia
AstraZeneca 197
Large-scale testing (Phase 3)Study completedNCT04959032
What this trial is testing

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 228
Not applicableNot Yet RecruitingNCT06042712
What this trial is testing

Belief-updating, Speech and Psychosis

Who this might be right for
Psychosis
King's College London 240
Large-scale testing (Phase 3)Study completedNCT00216476
What this trial is testing

Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen-Cilag International NV 753
Not applicableStudy completedNCT00358852
What this trial is testing

Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen-Cilag, S.A. 2,339
Next Page